A field based evaluation of adverse events following MenAfriVac, vaccine delivered in a controlled temperature chain (CTC) approach in Benin

A field based evaluation of adverse events following MenAfriVac, vaccine delivered in a controlled temperature chain (CTC) approach in Benin

INTRODUCTION: An estimated one hundred million African meningitis belt residents have received MenAfriVac, meningococcal serogroup A conjugate vaccine. Since October 2012 the vaccine has been licensed for use in a controlled temperature chain (CTC) approach, at temperatures of up to 40,C for up to f...

Full description

Bibliographic Details
Main Authors: Christoph Steffen, Evariste Tokplonou, Philippe Jaillard, Roger Dia, Marie NéDeye Bassabi Alladji, Bradford David Gessner
Format: Article
Language:English
Published: The Pan African Medical Journal 2014-08-01
Series:The Pan African Medical Journal
Subjects:
neisseria meningitidis a
meningococcus
meningitis belt
meningococcal conjugate vaccine; menafrivac
benin; mass vaccination
controlled temperature chain
pharmacovigilance
adverse events following immunization (aefi)
Online Access: https://www.panafrican-med-journal.com/content/article/18/344/pdf/344.pdf

Internet

https://www.panafrican-med-journal.com/content/article/18/344/pdf/344.pdf

Similar Items